SearchDictionaryMobileLogin

Polyhydramnios

319  relevant articles (10 outcomes, 11 trials/studies) found for this Disease

Description: A condition of abnormally high AMNIOTIC FLUID volume, such as greater than 2,000 ml in the LAST TRIMESTER and usually diagnosed by ultrasonographic criteria (AMNIOTIC FLUID INDEX). It is associated with maternal DIABETES MELLITUS; MULTIPLE PREGNANCY; CHROMOSOMAL DISORDERS; and congenital abnormalities.

Also Known As:
Hydramnios

Relationship Network

Disease Context: Research Results

Related Diseases

1. Fetofetal Transfusion (Twin Transfusion Syndrome)
2. Hydrops Fetalis (Fetal Edema)
3. Placenta Previa
4. Oligohydramnios
5. Premature Obstetric Labor (Premature Labor)

Experts

1. Taylor, Robert N: 2 articles (03/2006 - 06/2005)
2. Mann, Stephanie E: 2 articles (03/2006 - 06/2005)
3. Ward, Stuart: 2 articles (03/2004 - 07/2003)
4. Bajoria, Rekha: 2 articles (03/2004 - 07/2003)
5. Jayagopal, N: 1 article (11/2007)
6. Sinha, D: 1 article (11/2007)
7. Bhatti, N R: 1 article (11/2007)
8. Gilbert, Heather: 1 article (03/2006)
9. Dvorak, Natalia: 1 article (03/2006)
10. Torres, Elvina A: 1 article (06/2005)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Polyhydramnios:
1. Indomethacin (Indometacin)FDA LinkGeneric
2. Carbon MonoxideIBA
3. Ethanol (Ethyl Alcohol)IBA
4. Direction compoundIBA
5. alpha-Fetoproteins (AFP)IBA
6. ProlactinIBA
7. TOPSIBA
8. Matrix MetalloproteinasesIBA
9. Collagenases (Collagenase)FDA Link
10. Immunoglobulin M (IgM)IBA

Therapies and Procedures

1. Decompression
2. Renal Dialysis (Hemodialysis)
3. Cervical Cerclage
4. Induced Abortion (Induced Abortions)
01/01/1980 - "In 3 per cent of the cases there was a previous abortion and in 18 per cent it appeared that there was previous hydramnios. "
06/01/1990 - "An analysis of 30,621 consecutive deliveries showed that previous abortion, bleeding during pregnancy, polyhydramnios, oligohydramnios, operative delivery, multiple pregnancy, abnormal placentation, and primary cesarean were each associated with unexpectedly high transfusion rates. "
09/01/1975 - "When the effects of other variables were taken into account, there were no significant changes in frequency following an induced abortion as to: ABO and rhesus isoimmunization, toxemia, hydramnios, premature rupture of membranes, induction of labor, breech or vacuum delivery, cesarean section, breech presentation, placenta previa, placental abruption, cord prolapse, cord anomalies, fetal distress or asphyxia, post-partum hemorrhage."
03/01/1984 - "In the present studies, the content and the in vitro production of prolactin by decidua as well as the concentrations of prolactin in amniotic fluid, maternal and fetal serum in normal term pregnancies, induced abortions at various gestational ages, and in pregnancies complicated by diabetes mellitus, preeclampsia, chronic hypertension, and polyhydramnios were measured. "
08/01/1989 - "Of a total of 12,005 pregnancies (4561 Asian and 7444 White Caucasian), over a 3-year period, 314 (6.8%) Asian and 504 (6.7%) White Caucasian were given a 75-g oral glucose tolerance test (OGTT) at 28-32 weeks for indications of 'large for date' pregnancies, hydramnios, glycosuria, a history of previous abortions, stillbirths, congenital abnormalities or glucose intolerance, and family history of diabetes. "
Order ALL the reference details at left...
5. Ligation

Best Treatments:
Research Summary Report
on Polyhydramnios
*WARNING* This specific disease subtype has a relatively small number of significant evidence outcomes. You may proceed to order anyway, or go back to the search field and enter a more general type of the target illness. Once your report has been ordered, however, we can't refund the purchase.

CureHunter Patient-Physician Summary Reports collect in one document all the medications ever reported in the US National Library of Medicine—1949 to the present—to be effective against your target disease. CureHunter research summary reports will vary in length from 25 to 250 pages. Analytic charts allow you and your physicians to see at a glance your medication options—including new, promising, off-label and experimental all rated for clinical efficacy.
  • Free Updates for 1 Year
  • All 10 Outcomes
  • Top 122 Key Drugs and Biologics
  • Top 31 Key Therapies and Procedures
  • Detailed History Charts
  • Full Research Reference Details
  • Sample PDF Report on Psoriasis >>
Price:$24.00 & Delivery via PDF download
updates for 1 year
Research Interface

 

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.
  • Unlimited Disease, Drug and Therapy Search
  • 2 clicks from Disease to Drug to Evidence
  • Trial References
  • All the Positive Outcomes
  • Detailed Relationship Timeline Charts
  • Full Article Reference Details
  • Includes Mobile Interface Subscription
  • One-click to FDA Products/Patents
  • Request Institution License Details >>
Price:$490.00 access via web interface
1 year subscription
Proceed to Checkout >>
Mobile Interface

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.
  • Access from any web enabled PDA or Phone
  • Trial references
  • All the Positive Outcomes
  • Drug and Therapy searches
  • Full Article Reference Details
  • Try Mobile Interface >>
Price:$45.00 access via "curehunter.com/m"
1 year subscription
Proceed to Checkout >>